DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response

Journal of Viral Hepatitis

Volumn 11, Issue 1, 2004, Pages 18-26

  Jiao, X ^a   Wang, R Y H ^a   Feng, Z ^a   Hu, G ^a   Alter, H J ^a   Shih, J W K ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

DNA immunization; HCV NS3; Th1 response

Indexed keywords

CD4 ANTIGEN; MEMBRANE ANTIGEN; MONTIRELIN; VIRUS PROTEIN;

ANIMAL CELL; CELL ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; EXPERIMENTAL MODEL; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION; GENETIC CODE; HEPATITIS C; HEPATITIS C VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; NONHUMAN; PASSIVE IMMUNIZATION; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STATISTICAL ANALYSIS; TH1 CELL; VIRUS GENE; WESTERN BLOTTING;

ANIMALS; FEMALE; GENETIC VECTORS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKINS; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; PLASMIDS; SPLEEN; TH1 CELLS; VACCINATION; VACCINES, DNA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 1242337449     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1352-0504.2003.00464.x     Document Type: Conference Paper

References (37)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non A, non B viral hepatitis genome. Science 1989; 244: 359-361.
2. Cohen J. The scientific challenge of hepatitis C. Science 1999; 285: 26-30.
3. Poynard T, Marcellin P, Lee SS et al. Randomised trial of interferon a2b plus ribavirin for 48s week or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426-1432.
4. MaHutchison JG, Gorden SC, Schiff ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. New Engl J Med 1998; 339(21): 1485-1492.
5. Diepolder HM, Zachoval RM, Hoffmann RM et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346: 1006-1007.
6. Missale G, Bertoni R, Lamonaca V et al. Differentiate clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996; 98: 706.
7. Diepolder HM, Zachoval RM, Hoffmann RM, Jung MC, Gerlach T, Pape GR. The role of hepatitis C virus specific CD4+ Tlymphocytes in acute and chronic hepatitis C. J Mol Med 1996; 74: 583-588.
8. Tsai S-L, Liaw Y-F, Chen M-H, Huang C-Y, Guo GC. Detection of type-2 like T-helper cells in hepatitis C virus infection: implication for hepatitis C chronicity. Hepatology 1997; 25: 449-458.
9. Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C, Gastroenterology 2000; 118: 346-355.
10. Beckebaum S, Cicinnati VR, Gerken G. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis. Rev Med Virol 2002; 12: 297-319.
11. Chen Z, Wang RY-H, Alter HJ, Shih JW-K. Genetic immunization of mice with plasmids containing hepatitis C virus core protein-encoding DNA. Vaccine Research 1995; 4(3): 135-144.
12. Hu G-J, Wang RY-H, Han D-S, Alter HJ, Shih JW-K. Characterization of the humoral and cellular immune response against hepatitis C virus core induced by DNA-based immunization. Vaccine 1999; 17: 3160-3170.
13. Jiao X, Wang RY-H, Feng Z, Alter HJ, Shih JW-K. Modulation and enhancement of cellular immune response against non-structural protein 3 of hepatitis C virus by DNA immunization with cationic liposomes. Hepatology 2002; 37: 452-460.
14. Torres CAT, Yang K, Mustafa F, Robinson HL, DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses. Vaccine 2000; 18: 805-814.
15. Cho JH, Lee SW, Sung YC. Hepatitis C virus envelope DNA-based immunization elicits humoral and cellular immune responses. Mol Cells 1998; 8(4): 445-451.
16. Shevach EM. ELISPOT assay to detect cytokine-secreting murine and human cells. In: Coligan JE, Kruisbeek AM, Margilies DH, Shevach EM, eds. Current Protocol in Immunologyvol. I. New York: John Wiley & Sons, Inc., 1994: 6.19.1-6.19.8.
17. Lazdina U, Hultgren C, Frelin L et al. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus nonstructural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein. J Gen Virol 2001; 82(Pt 6): 1299-1308.
18. Gorden EJ, Bhat R, Liu Q, Wang Y-F, Tackney C, Prince AM. Immune responses to hepatitis C virus structural and nonstructral proteins induced by plasmid DNA immunizations. J Infec Dis 2000; 181: 42-50.
19. Encke J, zu Putlitz J, Geissler M, Wands JR. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J Immunol 1998; 161: 4917-4923.
20. Cho JH, Lee SW, Sung YC. Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization. Vaccine 1999; 17(9-10): 1136-1144.
21. Wedemeyer H, Gagneten S, Davis A, Bartenschlager R, Feinstone S, Rehermann B. Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model. Gastroenterology 2001; 121(5): 1158-1166.
22. Brinster C, Muguet S, Lone YC et al. Different hepatitis C virus nonstructural protein 3 (NS3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope. Hepatology 2001: 34(6): 1206-1217.
23. Boyle JS, Koniaras C, Lew AM. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramusclar DNA immunization. Int Immunol 1997; 9(12): 1897-1906.
24. Rehermann B. Cellular immune response to the hepatitis C virus. J Viral Hepat 1999; 6 (suppl. 1): 31-35.
25. Inchauspe G, Vitvitsiki L, Major ME et al. expressing a secreted or a non secreted form of hepatitis C virus nuleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol 1997; 16: 185-195.
26. Svanholm C, Bandholtz L, Lobell A, Wigzell H. Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion. J Immunol Meth 1999; 228: 121-130.
27. Kuhrober A, Wild J, Pudollek H-P, Chisari FV, Reimann J. DNA vaccination with plasmids encoding the intracellular (HbcAg) or secreted (HbeAg) form of the core protein of hepatitis B virus primes T cell responses to teo overlapping Kb-and Kd-restricted epitopes. Int Immunol 1997; 9(8): 1203-1212.
28. Hanke T, Blanchard TJ, Schneider J et al. Immunogenicities of intrvenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficency virus type 1 in mice. J Gen Virol 1998; 79: 83-90.
29. Degano P, Schneider J, Hannan CM, Gilbert SC, Hill AVS. Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models. Vaccine 2000; 18: 623-632.
30. Prange R, Werr M. DNA-mediated immunization to hepatitis B virus envelope proteins: preS antigen secretion enhances the humoral response. Vaccine 1999; 17: 617-623.
31. Drew DR, Lightowlers M, Strugnell RA. Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Taenia ovis 45W antigen. Vaccine 2000; 18: 2522-2532.
32. Haddad D, Liljeqvist S, Stahl S et al. Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice. FEMS Immunol Med Micro 1997; 18: 193-202.
33. Romagnani S. Lymphokine production by human T cells in disease states. Ann Rev Immunol 1994; 12: 227-257.
34. Fishman MA, Perelson AS. Th1/Th2 cross regulation. J Theor Biol 1994; 170: 25-26.
35. Woitas RP, Lechmann M, Jung G, Kaister R, Sauerbruch T, Spengler U. CD30 inductin and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol 1997; 159: 1012-1018.
36. Cerny A, Chisary FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999; 30(3): 595-601.
37. Tabatabai NM, Bian T-H, Rice CM, Yoshizawa K, Gill J, Eckels DD. Functionally Distinct T-cell epitopes within hepatitis C virus non-structural 3 protein. Human Immunol 1999; 60: 105-115.